Urolution Medical secures FDA clearance for OpenFlo urinary catheter

Natera secures FDA Breakthrough Device designation for multi-cancer early detection assay

Medincell partner Teva secures FDA approval for monthly schizophrenia treatment

FDA approves Genentech's Tecentriq combination therapy for stage III colon cancer

Lupin Limited receives FDA approval for Phytonadione Injectable Emulsion USP

argenx reports positive Phase 2 results for FB102 in coeliac disease

Vir Biotechnology's VIR-5500 receives FDA Fast Track designation for prostate cancer

FDA accepts Bayer's application for KERENDIA in chronic kidney disease without diabetes

Boehringer Ingelheim announces availability of new Quarterable Snap-Tab design for PREVICOX (firocoxib) Chewable Tablets

Okami Medical receives FDA approval for expanded indication of LOBO Vascular Occluder

Kedrion to be honoured at Premier's Supplier Innovation Celebration

Enliven Therapeutics reaches FDA alignment on relcobatinib (ELVN-001) Phase 3 trial design for previously treated CML

Zydus and MSN announce US launch of generic Adempas (Riociguat Tablets)

FDA approves second Reykjavik manufacturing suite for AVT02

Ractigen Therapeutics reports positive first-in-human data for RAG-18 in Duchenne muscular dystrophy